fda warning letter bpc-157 compounding pharmacy Proposed FDA Rule Could Limit
Description
BPC 157 klasyfikowany jest jako peptyd bioregulacyjny, co oznacza, e moe wpywa na rne procesy biologiczne w organizmie
In common with a number of other conditions, for example, Sjogren disease (1), one prominent clinical manifestation is a dysfunction of small nerve fibers that occurs in a patchy, nonlength-dependent manner (small fiber neuropathy [SFN])
In this context, it was shown that BPC 157 at a dose of 10 g/mL three times a week i.p
however, bulk active pharmaceutical ingredient retains potency for six months at 4 C if sealed with desiccant
